GeNeuro, Servier 'Disappointed' With Mid-Way Phase IIb Multiple Sclerosis Study

 
• By Sten Stovall

GeNeuro and partner Servier voiced disappointment over results seen midway through a Phase IIb trial studying a potential cause of multiple sclerosis - but insisted the trial will continue for the final 6 months.

Human brain
GeNeuro "Disappointed" With Mid-Way Results For CHANGE-MS Phase IIb Study • Source: Shutterstock

More from Clinical Trials

More from R&D